|
R31H
|
6 |
Minor effect |
1.91 |
T37A
|
6 |
Minor effect |
0.45 |
F41L
|
6 |
Minor effect |
1.23 |
R50C
|
1 |
Minor effect on antibody binding, but may improve RH5 binding by removing repulsion between CyRPA R50 and RH5 K504 |
1.11 |
D110N
|
2 |
Minor effect |
−2.02 |
I114V
|
2 |
Minor effect |
0.57 |
V165I
|
3 |
Minor effect; may alter CyRPA structure |
−0.99 |
F187L
|
3 |
Minor effect on antibody binding, but may affect binding to RH5 |
0.2 |
I196F
|
3 |
Minor effect on antibody binding, may affect binding to RH5; may alter CyRPA structure |
9.33 |
K211Q
|
4 |
Minor effect |
0.95 |
D236N
|
4 |
Add a new N-glycosylation site, minor effect |
0.05 |
D236V
|
4 |
Alter local structure through steric clash with S233, minor effect on antibody and RH5 binding |
0.09 |
N270T
|
4 |
Minor effect on antibody and RH5 binding; alter CyRPA structure, but abolishes a hydrogen bond between CyRPA N218 and N270 |
−0.03 |
V292F
|
5 |
Minor effect; may alter CyRPA structure |
8.54 |
N338D
|
6 |
Minor effect |
1.75 |